Rela Hospital in Chennai opens centre to treat neuroendocrine tumours

September 19, 2022 09:37 pm | Updated 09:37 pm IST - CHENNAI

Rela Hospital launched a Centre of Excellence for Neuroendocrine Tumours on Monday.

Nobel Laureate Ada E. Yonath commissioned the centre. Neuroendocrine tumours begin in neuroendocrine cells with traits similar to nerve cells and hormone-producing cells. Neuroendocrine tumours, more common in gastrointestinal tract, lungs, pancreas, appendix, small intestine and rectum, can occur in almost any organ.

The centre will have oncologists, pathologists, radiologists, nuclear medicine experts, endocrinologists, surgeons, gastroenterologists and nurses. Hospital CEO K. Ilankumaran Kaliamoorthy said the new speciality was developed to address a rare tumour.

C.S. Mani, senior consultant, surgical oncology, said the neuroendocrine was a special group of cells scattered across the body. “Although they are present for a specific purpose they can unusually give rise to cancer of different types. In recent times, there has been an increase in the recognition of the tumour. A few renowned celebrities like Steve Jobs, Irfan khan and Aretha Franklin were affected with this tumour. It is increasing in incidence all over the world compared to last 10 to 15 years,” he said.

Prof. Yonath said: “With the expertise and knowledge of the team of oncologists here, I am confident that patients with this life-threatening cancer will get the best treatment.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.